New-onset or pre-existing AF predicted acute ischemic stroke or TIA in patients with cancer -- as did renal disease, dyslipidemia, and active cancer therapy -- in a case-control study.

A study suggests that postoperative care should account for the unique biological and psychosocial factors that influence outcomes in women.

Assessing when to initiate anticoagulation in atrial fibrillation is not improved by including gender, says the ESC in their latest guidelines, and can end up penalizing women.

The common irregular heartbeat known as atrial fibrillation (A-fib) may increase the risk of dementia, a new study suggests. Researchers found that people newly diagnosed with a-fib had a 13% higher risk of developing dementia, the progressive loss of memory and thinking...

High-volume centers with more than 100 operators have gathered data on 7000 patients and counting to continually improve outcomes.

In patients with cryptogenic stroke and evidence of atrial cardiopathy without atrial fibrillation, apixaban did not reduce recurrent stroke vs aspirin in the ARCADIA trial.

Atrial fibrillation has been linked to cognitive decline, but a randomized anticoagulation trial, halted early for futility, suggests microemboli are not responsible.

Dose reductions of edoxaban in patients over 80 years of age with atrial fibrillation produced a lower risk for bleeding.

For patients with atrial fibrillation who need protection from stroke and other complications after ablation, left atrial appendage closure rivaled oral anticoagulation in a randomized trial.

Atrial high-rate episodes are associated with more than twice the risk for mortality in patients with an implantable cardioverter defibrillator or cardiac resynchronization therapy defibrillator.

The long-standing debate as to when to start anticoagulation in patients with an acute ischemic stroke and atrial fibrillation looks as though it is settled.

Medtronic's PulseSelect Pulsed Field Ablation System was approved for the treatment of paroxysmal and persistent atrial fibrillation.

Atrial fibrillation improved when linear ablation and ethanol infusion were added to pulmonary vein isolation in a randomized multicenter trial, but not all experts are convinced.

Instead of narrowing down the field of suspects in ESUS, new research is adding more.

Extending the simple CT scan administered to all acute stroke patients to include the upper part of the heart increased cardioaortic thrombus detection by almost sixfold.

Advances in stroke, a novel antihypertensive, and new evidence that diabetes drugs may offer CVD benefits for those without diabetes are among the top developments in 2023, on the AHA's annual list.

The rhythm disorder is a complex multifactorial disease, according to new atrial fibrillation guidelines released by the European Society of Cardiology that are revamping the approach to care.

A new study found the lifetime risks of post-AF stroke, ischemic stroke, and myocardial infarction improved remained high, with virtually no improvement in the lifetime risk for heart failure.

The OCEANIC-AF trial has raised concerns about factor XI inhibitors. Should physicians still bet on this class of anticoagulants?

The Amulet and Watchman FLX devices for left atrial appendage closure produced equivalent results, with about half of patients having residual patency of the appendage at 13 months, a study shows.